147 related articles for article (PubMed ID: 16454812)
1. Expression of TNF-alpha in oral lichen planus treated with fluocinolone acetonide 0.1%.
Thongprasom K; Dhanuthai K; Sarideechaigul W; Chaiyarit P; Chaimusig M
J Oral Pathol Med; 2006 Mar; 35(3):161-6. PubMed ID: 16454812
[TBL] [Abstract][Full Text] [Related]
2. Expression of IFN-gamma before and after treatment of oral lichen planus with 0.1% fluocinolone acetonide in orabase.
Youngnak-Piboonratanakit P; Dhanuthai K; Thongprasom K; Luckprom P; Sarideechaigul W; Luangjarmekorn L; Azuma M
J Oral Pathol Med; 2009 Oct; 38(9):689-94. PubMed ID: 19614863
[TBL] [Abstract][Full Text] [Related]
3. Clinical evaluation in treatment of oral lichen planus with topical fluocinolone acetonide: a 2-year follow-up.
Thongprasom K; Luengvisut P; Wongwatanakij A; Boonjatturus C
J Oral Pathol Med; 2003 Jul; 32(6):315-22. PubMed ID: 12787037
[TBL] [Abstract][Full Text] [Related]
4. Effect of fluocinolone acetonide (0.1%) treatment in oral lichen planus patients on salivary lactoferrin levels and Candida colonization: a prospective study.
Saengprasittichok N; Sucharitakul J; Matangkasombut O; Prapinjumrune C
BMC Oral Health; 2022 Mar; 22(1):58. PubMed ID: 35246095
[TBL] [Abstract][Full Text] [Related]
5. A randomized-controlled trial to compare topical cyclosporin with triamcinolone acetonide for the treatment of oral lichen planus.
Thongprasom K; Chaimusig M; Korkij W; Sererat T; Luangjarmekorn L; Rojwattanasirivej S
J Oral Pathol Med; 2007 Mar; 36(3):142-6. PubMed ID: 17305635
[TBL] [Abstract][Full Text] [Related]
6. Salivary levels of tumor necrosis factor-alpha in oral lichen planus.
Pezelj-Ribaric S; Prso IB; Abram M; Glazar I; Brumini G; Simunovic-Soskic M
Mediators Inflamm; 2004 Apr; 13(2):131-3. PubMed ID: 15203556
[TBL] [Abstract][Full Text] [Related]
7. [Levels of interlukin-6 and tumor necrosis factor-α in saliva of patients with type 2 diabetes mellitus and oral lichen planus].
Liu Y; Jin JQ; Yuan ZF; Liu XS; Cao J; Guo XH; Liu HW
Beijing Da Xue Xue Bao Yi Xue Ban; 2011 Aug; 43(4):596-9. PubMed ID: 21844975
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of topical retinoic acid compared with topical fluocinolone acetonide in the treatment of oral lichen planus.
Buajeeb W; Kraivaphan P; Pobrurksa C
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 1997 Jan; 83(1):21-5. PubMed ID: 9007918
[TBL] [Abstract][Full Text] [Related]
9. TNF-alpha expression and apoptosis-regulating proteins in oral lichen planus: a comparative immunohistochemical evaluation.
Sklavounou A; Chrysomali E; Scorilas A; Karameris A
J Oral Pathol Med; 2000 Sep; 29(8):370-5. PubMed ID: 10972345
[TBL] [Abstract][Full Text] [Related]
10. Activation of nuclear factor-kappa B correlates with tumor necrosis factor-alpha in oral lichen planus: a clinicopathologic study in atrophic-erosive and reticular form.
Zhou G; Xia K; Du GF; Chen XM; Xu XY; Lu R; Zhou HM
J Oral Pathol Med; 2009 Aug; 38(7):559-64. PubMed ID: 19453840
[TBL] [Abstract][Full Text] [Related]
11. The molecular mechanisms of the effect of Dexamethasone and Cyclosporin A on TLR4 /NF-κB signaling pathway activation in oral lichen planus.
Ge Y; Xu Y; Sun W; Man Z; Zhu L; Xia X; Zhao L; Zhao Y; Wang X
Gene; 2012 Oct; 508(2):157-64. PubMed ID: 22903029
[TBL] [Abstract][Full Text] [Related]
12. Osteopontin expression in oral lichen planus.
Zhou ZT; Wei BJ; Shi P
J Oral Pathol Med; 2008 Feb; 37(2):94-8. PubMed ID: 18197854
[TBL] [Abstract][Full Text] [Related]
13. Elevated serum levels of the apoptosis related molecules TNF-alpha, Fas/Apo-1 and Bcl-2 in oral lichen planus.
Sklavounou-Andrikopoulou A; Chrysomali E; Iakovou M; Garinis GA; Karameris A
J Oral Pathol Med; 2004 Aug; 33(7):386-90. PubMed ID: 15250829
[TBL] [Abstract][Full Text] [Related]
14. TNF-α, TNF-β and IL-10 gene polymorphism and association with oral lichen planus risk in Saudi patients.
Al-Mohaya MA; Al-Harthi F; Arfin M; Al-Asmari A
J Appl Oral Sci; 2015; 23(3):295-301. PubMed ID: 26221924
[TBL] [Abstract][Full Text] [Related]
15. Th1/Th2 cytokine ratio in tissue transudates from patients with oral lichen planus.
Rhodus NL; Cheng B; Ondrey F
Mediators Inflamm; 2007; 2007():19854. PubMed ID: 17497029
[TBL] [Abstract][Full Text] [Related]
16. Relative efficacy of fluocinolone acetonide compared with triamcinolone acetonide in treatment of oral lichen planus.
Thongprasom K; Luangjarmekorn L; Sererat T; Taweesap W
J Oral Pathol Med; 1992 Nov; 21(10):456-8. PubMed ID: 1460584
[TBL] [Abstract][Full Text] [Related]
17. Oral lichen planus: clinical presentation and management.
Edwards PC; Kelsch R
J Can Dent Assoc; 2002 Sep; 68(8):494-9. PubMed ID: 12323106
[TBL] [Abstract][Full Text] [Related]
18. Higher expressions of p53 and proliferating cell nuclear antigen (PCNA) in atrophic oral lichen planus and patients with areca quid chewing.
Lee JJ; Kuo MY; Cheng SJ; Chiang CP; Jeng JH; Chang HH; Kuo YS; Lan WH; Kok SH
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2005 Apr; 99(4):471-8. PubMed ID: 15772596
[TBL] [Abstract][Full Text] [Related]
19. Foxp3 gene expression in oral lichen planus: a clinicopathological study.
Lei L; Zhan L; Tan W; Chen S; Li Y; Reynolds M
Mol Med Rep; 2014 Mar; 9(3):928-34. PubMed ID: 24469541
[TBL] [Abstract][Full Text] [Related]
20. A randomized controlled trial to compare steroid with cyclosporine for the topical treatment of oral lichen planus.
Yoke PC; Tin GB; Kim MJ; Rajaseharan A; Ahmed S; Thongprasom K; Chaimusik M; Suresh S; Machin D; Bee WH; Seldrup J;
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2006 Jul; 102(1):47-55. PubMed ID: 16831672
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
